February 3rd, 2014
Selections from Richard Lehman’s Literature Review: February 3rd
Richard Lehman, BM, BCh, MRCGP
This week’s topics include biomarkers for systemic sclerosis, the effectiveness of ICDs for primary prevention of sudden cardiac death, and more.
January 6th, 2014
Selections from Richard Lehman’s Literature Review: January 6th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the NAVIGATOR study, trials of stents, mitral valve repair vs. replacement, and more.
NEJM — Recent Cardiology Articles- Platelet-Activating Anti–Platelet Factor 4 Disorders July 13, 2026This review summarizes platelet-activating anti–platelet factor 4 disorders, including heparin-induced thrombocytopenia and related syndromes, highlighting diagnosis, antibody mechanisms, and treatment strategies.
- Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty July 12, 2026After total hip or knee arthroplasty, aspirin alone was noninferior to rivaroxaban followed by aspirin in preventing symptomatic venous thromboembolism, with a similarly low risk of bleeding complications.
- Descending Thoracic Aortic Aneurysm July 11, 2026A man presented with a 2-month history of chest heaviness and a 2-week history of shortness of breath. Pulsations were visible between his ribs (shown in a video). Ultrasonography revealed a rounded structure near the heart.
- Trends and Prevalence of Chronic Kidney Disease in the United States July 9, 2026Updated estimates of the prevalence of CKD in the United States indicate that the overall national burden of CKD has remained stable, but an increasing proportion is associated with diabetes.
- A Rash and Red Urine July 9, 2026This interactive feature describes a 73-year-old man with a history of heart failure who presented to the ED with a rash, weight gain, dyspnea, and new-onset visible hematuria. Test your diagnostic and therapeutic skills at NEJM.org.
- Platelet-Activating Anti–Platelet Factor 4 Disorders July 13, 2026